Transparency on trial: How to navigate FDAAA 801 final rule implementation and compliance

October 9, 2018

As seen in Outsourcing-Pharma.com - Posted Oct. 9, 2018 - Original Article

April 5, 2018 | By Melissa Fassbender | Regulations are changing across the globe as patients, the scientific community, and other stakeholders call for increased clinical trial data transparency.


Continued on Outsourcing-Pharma

Previous Article
Clinical Trial Sponsors Take Heed: Study Disclosure Rules Are Expanding
Clinical Trial Sponsors Take Heed: Study Disclosure Rules Are Expanding

Next Article
FDA to Begin Publishing Clinical Study Reports & Possibly Select CRLs
FDA to Begin Publishing Clinical Study Reports & Possibly Select CRLs